JPME JPMorgan Diversified Return U.S. Mid Cap Equity ETF

Expense Ratio
0.24%
Dividend
1.88%
Previous close
$118.50
Est. 12 months change
+11.32%
Projected Price
$131.92

Profitability Metrics

Return on Equity (ROE)
19.71%
Return on Assets (ROA)
6.41%
Return on Invested Capital (ROIC)
17.88%
Weighted Average Cost of Capital (WACC)
7.74%
ROIC - WACC
10.13%
Updated : 2026-05-15 21:03 ET

Valuation Metrics

P/E Ratio
18.71
Forward P/E
14.30
PEG Ratio
3.34
Debt Current Ratio
2.02

Growth & Cash Flow

Gross Margin
45.73%
Operating Margin
21.06%
FCF Margin
14.18%
TTM Revenue Growth
15.84%
Projected 12M EPS Growth
30.86%

Price Change

Price % from 50 SMA
0.75%
Price % from 200 SMA
5.96%
6 Months
10.96%
1 Year
15.38%
2 Years
20.05%
The above metrics represent weighted averages, calculated using each stock's individual value weighted by its proportion of ETF holdings.

Top 10 Holdings

Stock TickerWeight
WDC0.78%
CIEN0.76%
LITE0.68%
DVN0.65%
GLW0.62%
MPWR0.60%
JBL0.56%
ESI0.55%
PWR0.55%
FLEX0.54%

ETF Analysis

Fund Overview

JPMorgan Diversified Return U.S. Mid Cap Equity ETF (JPME) currently reports 349 stock positions (subject to change), placing it in the highly diversified range by holdings breadth. The top line-up is WDC (0.78%), CIEN (0.76%), LITE (0.68%), with WDC as the largest single weight at 0.78%. Together, the top three holdings account for 2.22%, which implies a more democratized weight structure where the broader holding set matters as much as the leadership group. This structure gives the portfolio a dual character: meaningful exposure to its highest-conviction names, alongside enough breadth to dampen idiosyncratic noise.

Profitability & Capital Efficiency

Examining the portfolio through a capital allocation lens, ROIC is 17.88%, WACC is 7.74%, and the economic spread is 10.13%. On balance, the spread between ROIC and WACC is solidly positive — reinvestment is adding value rather than diluting it. Supporting metrics show ROE at 19.71% and ROA at 6.41%, a combination that helps frame whether profitability strength is broad enough to hold through different market conditions. Taken together, the return profile suggests a portfolio with credible compounding capacity if current operating execution persists.

Valuation

Valuation currently screens at trailing P/E of 18.71, forward P/E of 14.30, PEG of 3.34. Trailing and forward P/E are close together, implying the market does not expect a significant change in the earnings trajectory over the near term. At this PEG level, the portfolio is priced generously relative to its expected earnings trajectory — execution risk is meaningfully priced in. The aggregate current ratio of 2.02 reflects a holding set with workable near-term liquidity positions. The valuation profile here is neither obviously cheap nor dramatically expensive — a setup where the return case is built more on earnings delivery than on re-rating potential.

Margins & Cash Generation

From gross to free cash flow, gross margin sits at 45.73%, operating margin at 21.06%, and free cash flow margin at 14.18%. At this gross margin level, the holdings demonstrate adequate production efficiency without commanding premium pricing. The operating margin reading is healthy — adequate to support reinvestment without sacrificing profitability. The portfolio's FCF margin is modest — adequate for near-term needs but not indicative of exceptional capital efficiency. The margin profile warrants careful consideration — businesses with compressed margins have less room to absorb cost pressure or revenue softness.

Growth & Forward Outlook

Revenue momentum and analyst targets together paint a picture where the estimated 12-month price change of 11.43%, where consensus expectations favor gradual appreciation over the next year, while TTM revenue growth of 15.84% reflecting moderate but reliable revenue progress across the basket. Reported revenue growth is the operational foundation; the analyst target spread shows what the market is willing to pay above it — and that premium can evaporate quickly if delivery slips. For investors, the central question is whether the operating momentum visible in revenues is durable enough to support the price appreciation implied by consensus targets. The estimated 12-month price change is a weighted composite of analyst price target estimates adjusted by each holding's ETF weight, sourced from publicly available data, and should not be interpreted as a reliable prediction of future performance.

Conclusion

Buy

The fundamental case holds up across most key dimensions — the combination of positive economic spread, reasonable valuation, and analyst support is constructive.

These findings are based solely on the metrics presented and do not constitute an investment recommendation. Always perform your own due diligence before committing capital.